#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	11682	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2097	550.1	1	SNP	n	C1184T	0	.	.	1184	1184	C	1409	1409	C	700	C	677	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	11682	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2097	550.1	0	HET	.	.	.	C451T	.	451	451	C	676	676	C	690	C,T	470,194	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	11682	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2097	550.1	0	HET	.	.	.	C207T,A,G	.	207	207	C	432	432	C	610	C,T,A,G	468,116,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	22004	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3477	627.6	0	.	n	.	0	T695C	SNP	695	695	T	1031	1031	C	667	C,T	632,7	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	22004	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3477	627.6	0	.	n	.	0	T1971C	SNP	1971	1971	T	2307	2307	C	673	C	642	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	22004	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3477	627.6	1	SNP	n	A2045G	0	.	.	2045	2045	A	2381	2381	A	695	A	674	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	22004	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3477	627.6	1	SNP	n	C2597T	0	.	.	2597	2597	C	2933	2933	C	622	C,T,G	599,2,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	1280	folP	855	855	100.0	folP.l15.c17.ctg.1	1499	84.3	1	SNP	p	R229S	1	.	.	685	687	AGC	1003	1005	AGC	139;142;143	A;G;C	136;137;139	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	3698	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3346	109.8	1	SNP	p	S91F	1	.	.	271	273	TTC	581	583	TTC	110;111;114	T;T;C	107;108;110	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	3698	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3346	109.8	1	SNP	p	D95G	1	.	.	283	285	GGC	593	595	GGC	115;114;115	G,A;G;C	110,1;110;112	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	3698	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3346	109.8	1	SNP	p	G95N	0	.	.	283	285	GGC	593	595	GGC	115;114;115	G,A;G;C	110,1;110;112	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	27	1110	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1384	79.9	1	SNP	p	G45D	0	.	.	133	135	GGC	481	483	GGC	130;132;132	G;G;C	127;129;127	mtrR.WHO_V_01454:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	612	mtrR_promoter	250	250	99.6	mtrR_promoter.l6.c4.ctg.1	980	61.8	0	.	n	.	0	A197.	DEL	197	197	A	586	586	A	139	A	137	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4370	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3068	141.4	1	SNP	p	D86N	0	.	.	256	258	GAC	571	573	GAC	153;152;154	G;A;C,T	148;143;147,1	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4370	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3068	141.4	1	SNP	p	R87W	0	.	.	259	261	CGT	574	576	CGT	153;153;154	C;G;T	147;145;145	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4370	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3068	141.4	1	SNP	p	R87I	0	.	.	259	261	CGT	574	576	CGT	153;153;154	C;G;T	147;145;145	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4370	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3068	141.4	1	SNP	p	S87R	1	.	.	259	261	CGT	574	576	CGT	153;153;154	C;G;T	147;145;145	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4370	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3068	141.4	1	SNP	p	S88P	0	.	.	262	264	TCC	577	579	TCC	154;154;154	T;C;C	143;146;148	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3026	parE	1986	1986	100.0	parE.l6.c4.ctg.1	2676	112.4	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1612	1614	GGC	144;142;142	G;G;C	137;136;136	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	3080	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2559	118.9	1	SNP	p	A311V	0	.	.	931	933	GCC	1307	1309	GCC	175;177;177	G;C;C,A	167;172;170,1	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3080	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2559	118.9	1	SNP	p	I312M	1	.	.	934	936	ATG	1310	1312	ATG	176;178;176	A;T,A;G,C	170;173,1;170,1	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3080	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2559	118.9	1	SNP	p	V316T	1	.	.	946	948	ACC	1322	1324	ACC	167;166;167	A;C;C	158;163;161	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3080	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2559	118.9	1	SNP	p	T316P	0	.	.	946	948	ACC	1322	1324	ACC	167;166;167	A;C;C	158;163;161	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3080	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2559	118.9	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1823	1825	ACC	158;157;159	A,G;C;C	143,1;154;153	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3080	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2559	118.9	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1877	1879	GCG	157;158;156	G;C;G,A	150;151;148,1	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3080	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2559	118.9	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1877	1879	GCG	157;158;156	G;C;G,A	150;151;148,1	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3080	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2559	118.9	1	SNP	p	G542S	0	.	.	1624	1626	GGT	2000	2002	GGT	117;118;116	G;G;T,C	114;113;106,4	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3080	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2559	118.9	1	SNP	p	G545S	1	.	.	1633	1635	AGC	2009	2011	AGC	113;112;110	A,G;G;C	104,3;108;106	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3080	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2559	118.9	1	SNP	p	P551S	0	.	.	1651	1653	CCG	2027	2029	CCG	95;97;96	C,G,T;C,G;G	81,3,1;84,2;81	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	4788	ponA	2397	2397	100.0	ponA.l6.c30.ctg.1	3336	142.8	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1772	1774	CCG	174;174;174	C;C;G	162;170;164	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	1844	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1797	101.9	0	.	p	.	0	M83fs	FSHIFT	247	247	A	585	585	C	155	C	146	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	266	porB1a	984	282	90.91	porB1a.l15.c30.ctg.1	1230	19.5	0	.	p	.	0	H217N	NONSYN	649	651	CAT	973	975	AAT	11;11;11	A;A;T	11;11;11	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	266	porB1a	984	282	90.91	porB1a.l15.c30.ctg.1	1230	19.5	0	.	p	.	0	D218N	NONSYN	652	654	GAT	976	978	AAT	10;10;10	A;A;T	10;10;10	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	266	porB1a	984	282	90.91	porB1a.l15.c30.ctg.1	1230	19.5	0	.	p	.	0	V226A	NONSYN	676	678	GTA	1000	1002	GCA	10;10;9	G;C;A	10;10;9	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	266	porB1a	984	282	90.91	porB1a.l15.c30.ctg.1	1230	19.5	0	.	p	.	0	.	MULTIPLE	700	702	ACT	1023	1025	GTA	5;5;5	G;T;A	5;5;5	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	266	porB1a	984	282	90.91	porB1a.l15.c30.ctg.1	1230	19.5	0	.	p	.	0	N237fs	FSHIFT	709	709	A	1032	1032	A	6	A	6	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2614	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	1675	154.8	0	.	p	.	0	E209K	NONSYN	625	627	GAA	923	925	AAA	212;213;213	A;A;A	208;208;210	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2614	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	1675	154.8	0	.	p	.	0	A212E	NONSYN	634	636	GCA	932	934	GAA	219;218;217	G;A;A	210;212;213	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2614	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	1675	154.8	1	SNP	p	G120K	1	.	.	358	360	AAG	656	658	AAG	219;216;208	A,C;A;G	210,1;207;192	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2614	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	1675	154.8	1	SNP	p	A121N	1	.	.	361	363	AAC	659	661	AAC	206;202;202	A,G;A;C	190,6;196;196	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2614	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	1675	154.8	1	SNP	p	N121D	0	.	.	361	363	AAC	659	661	AAC	206;202;202	A,G;A;C	190,6;196;196	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	9230	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4841	189.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1088	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1060	102.0	1	SNP	p	V57M	1	.	.	169	171	ATG	529	531	ATG	209;209;210	A;T;G	202;200;202	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
